Fund Holdings — Omega Fund Management, LLC

Total Portfolio Value:
$125.16M
Total Bought:
$4.00M
Total Sold:
$52.11M
Net Transaction:
-$48.11M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Nuvation Bio Inc.CL A(NUVB)8,081,0897,151,031-930,058$45.90M$40.05M31.99%-$5.85M
Bicara Therapeutics Inc.1,822,1501,759,912-62,238$54.10M$32.75M26.17%-$21.35M
Beta Bionics, Inc.(BBNX)1,316,183962,010-354,173$20.62M$18.26M14.59%-$2.37M
BridgeBio Oncology Therapeutics, Inc.(BBOT)3,289,6613,289,6610$25.07M$13.49M10.78%-$11.58M
Kestra Med Technologies Ltd
SHS
1,022,149362,394-659,755$26.00M$10.25M8.19%-$15.75M
Immunic, Inc.(IMUX)0430,180+430,180$0$4.00M3.20%+$4.00M
Sana Biotechnology, Inc.(SANA)843,750843,7500$2.94M$2.46M1.97%-$480.9K
ImageneBio, Inc.(IMA)455,361455,3610$2.69M$2.09M1.67%-$601.1K
enGene Holdings Inc.
COM
876,357876,3570$1.52M$1.75M1.40%+$236.6K
Odyssey Therapeutics Inc.2,8932,8930$54.1K$64.3K0.05%+$10.2K
Alumis Inc.241,2550-241,255$6.79M$0—-$6.79M
Page 1 of 1
Omega Fund Management, LLC — 13F Holdings — Q3 2026 | TickerTrail